Nippon India Pharma Fund-Growth Plan-Growth Option

Nav: ₹ 517.0466 ↑ 0.35%
[as on 11 September, 2025]

Nav chart with 500 day SMA

SMA

  • 100 SMA
  • 200 SMA
  • 300 SMA
  • 400 SMA
  • 500 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Nippon India Pharma Fund-Growth Plan-Growth Option -2.33% 0.35% 0.28% 1.98% 0.46% -0.97% 22.84% 19% 18.03% 13.45%

Portfolio

Equity

NameSectorWeight %
Sun Pharmaceutical Industries LimitedPharmaceuticals & Biotechnology11.94 %
Divi's Laboratories LimitedPharmaceuticals & Biotechnology7.34 %
Cipla LimitedPharmaceuticals & Biotechnology6.09 %
Lupin LimitedPharmaceuticals & Biotechnology6.09 %
Apollo Hospitals Enterprise LimitedHealthcare Services5.91 %
Dr. Reddy's Laboratories LimitedPharmaceuticals & Biotechnology5.90 %
MedPlus Health Services LimitedRetailing3.65 %
Vijaya Diagnostic Centre LimitedHealthcare Services3.48 %
GlaxoSmithKline Pharmaceuticals LimitedPharmaceuticals & Biotechnology3.04 %
Gland Pharma LimitedPharmaceuticals & Biotechnology2.96 %
Ajanta Pharma LimitedPharmaceuticals & Biotechnology2.84 %
Thyrocare Technologies LimitedHealthcare Services2.63 %
Abbott India LimitedPharmaceuticals & Biotechnology2.59 %
Sai Life Sciences LimitedPharmaceuticals & Biotechnology2.52 %
Dr. Lal Path Labs LimitedHealthcare Services2.41 %
Zydus Lifesciences LimitedPharmaceuticals & Biotechnology2.35 %
Mankind Pharma LimitedPharmaceuticals & Biotechnology2.24 %
Narayana Hrudayalaya LimitedHealthcare Services2.16 %
Aurobindo Pharma LimitedPharmaceuticals & Biotechnology2.09 %
JB Chemicals & Pharmaceuticals LimitedPharmaceuticals & Biotechnology2.06 %
Alkem Laboratories LimitedPharmaceuticals & Biotechnology2.05 %
Pfizer LimitedPharmaceuticals & Biotechnology1.96 %
Biocon LimitedPharmaceuticals & Biotechnology1.76 %
Sanofi India LimitedPharmaceuticals & Biotechnology1.42 %
Suraksha Diagnostic LimitedHealthcare Services1.39 %
Sanofi Consumer Healthcare India LimitedPharmaceuticals & Biotechnology1.33 %
IPCA Laboratories LimitedPharmaceuticals & Biotechnology1.30 %
Torrent Pharmaceuticals LimitedPharmaceuticals & Biotechnology1.29 %
Fortis Healthcare LimitedHealthcare Services1.20 %
Anthem Biosciences LimitedPharmaceuticals & Biotechnology1.04 %
Syngene International LimitedHealthcare Services0.96 %
Akums Drugs and Pharmaceuticals LimitedPharmaceuticals & Biotechnology0.82 %
Emcure Pharmaceuticals LimitedPharmaceuticals & Biotechnology0.78 %
AstraZeneca Pharma India LimitedPharmaceuticals & Biotechnology0.63 %
Indoco Remedies LimitedPharmaceuticals & Biotechnology0.59 %
Orchid Pharma LimitedPharmaceuticals & Biotechnology0.43 %
Concord Biotech LimitedPharmaceuticals & Biotechnology0.22 %

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The latest NAV of Nippon India Pharma Fund-Growth Plan-Growth Option is 517.0466 as on 11 September, 2025.
  • What are YTD (year to date) returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The YTD (year to date) returns of Nippon India Pharma Fund-Growth Plan-Growth Option are -2.33% as on 11 September, 2025.
  • What are 1 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 1 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option are -0.97% as on 11 September, 2025.
  • What are 3 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 3 year annualized returns of Nippon India Pharma Fund-Growth Plan-Growth Option are 22.84% as on 11 September, 2025.
  • What are 5 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 5 year annualized returns of Nippon India Pharma Fund-Growth Plan-Growth Option are 19% as on 11 September, 2025.